REQUEST A DEMO
Total
USD $0.00
Search more companies

Medipharco Pharmaceutical Joint Stock Company (Hue) (Vietnam)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Medipharco Pharmaceutical Joint Stock Company Profile Updated: March 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medipharco Pharmaceutical Joint Stock Company, also known as Medipharco, is a pharmaceutical company located in Hue, Vietnam. It was first established on April 8, 4, after the country's liberation and reunification. The company has undergone several name changes throughout its history, including Thua Thien Hue Pharmaceutical Company, Binh – Tri – Thien Pharmaceutical Union Enterprise, Thua Thien Hue Pharmaceutical Enterprise, and Thua Thien Hue Pharmaceutical Company. In 1999, the Ministry of Health designated Medipharco as a member unit of Vietnam Pharmaceutical Corporation and changed its name to Hue Central Pharmaceutical Company. The company was later equitized and renamed TW Medipharco Pharmaceutical Joint Stock Company. It was approved by the State Securities Commission to increase its charter capital and changed its name to Medipharco -Tenamyd Central Pharmaceutical Joint Stock Company. Medipharco is involved in the production, trading, and import-export of medicines, medical instruments, supplies and equipment, cosmetic products, hygiene products, biological products, essential oils, and flavorings. The company also provides healing medicine storage services and is engaged in financial investment, market research, opinion polling services, real estate business, and alcohol production and trading. Medipharco is listed on the UPCOM exchange of the Hanoi Stock Exchange, with the stock code MTP. In 2011, the company established a joint venture called Medipharco Tenamyd BR Pharmaceutical Joint Stock Company with Tenamyd Cosmetic Pharmaceutical Joint Stock Company and Bruschettini – S.R.L / Italy Co., Ltd. The parent company of the joint venture is TW Medipharco-Tenamyd Pharmaceutical Joint Stock Company. In 2017, the company changed its name to Medipharco Pharmaceutical Joint Stock Company. On January 1, 1, the company merged with Medipharco-Tenamyd BR s.r.l Pharmaceutical Joint Venture JSC.

Headquarters
8 Nguyen Truong To St, Phuoc Vinh Ward
Hue; North Central Coastal Vietnam; Postal Code: 53

Contact Details: Purchase the Medipharco Pharmaceutical Joint Stock Company (Hue) report to view the information.

Website: http://www.medipharco.com.vn

Basic Information
Total Employees:
Purchase the Medipharco Pharmaceutical Joint Stock Company (Hue) report to view the information.
Outstanding Shares:
Purchase the Medipharco Pharmaceutical Joint Stock Company (Hue) report to view the information.
Registered Capital:
Purchase the Medipharco Pharmaceutical Joint Stock Company (Hue) report to view the information.
Financial Auditors:
Purchase the Medipharco Pharmaceutical Joint Stock Company (Hue) report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Controller/Comptroller
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Medipharco Pharmaceutical Joint Stock Company (Hue) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
-6.23%
Total operating revenue
-6.23%
Operating profit (EBIT)
14.63%
EBITDA
5.1%
Net Profit (Loss) for the Period
251.56%
Total assets
10.05%
Total equity
13.68%
Operating Profit Margin (ROS)
0.69%
Net Profit Margin
0.95%
Return on Equity (ROE)
10.67%
Debt to Equity Ratio
7.86%
Quick Ratio
0.1%
Cash Ratio
0.04%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?